Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis

Enzyme and Protein

Volumn 49, Issue 1-3, 1996, Pages 138-162

  Pepper, Michael S ^a   Montesano, Roberta ^a   Mandriota, Stefano J ^a   Orci, Lelio ^a   Vassalli, Jean Dominique ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Angiogenesis; Extracellular matrix; Plasminogen activator inhibitor 1; Polyoma virus middle T oncogene; Tissue type plasminogen activator; Urokinase type plasminogen activator

Indexed keywords

CYTOKINE; PLASMIN; PLASMINOGEN ACTIVATOR; PROTEINASE; PROTEINASE INHIBITOR; UROKINASE;

ANGIOGENESIS; CAPILLARY; CELL MIGRATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MORPHOGENESIS; NONHUMAN; PROTEIN DEGRADATION; REVIEW;

POLYOMAVIRUS;

EID: 0029953671     PISSN: 10196773     EISSN: None     Source Type: Journal    
DOI: 10.1159/000468622     Document Type: Review

References (94)

1. Evans HM: On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries. Anat Rec 1909:3:498-519.
2. Risau W: Differentiation of endothelium. FASEB J 1995:9:926-933.
3. Folkman J: Tumor angiogenesis, Adv Cancer Res 1974:19:331-358.
4. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995:1:149-153.
5. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis. Microvasc Res 1977:14:52-65.
6. Paku S, Paweletz N: First steps of tumor-related angiogenesis. Lab Invest 1991 ;65:334-346.
7. Pepper MS, Ferrara N, Orci L, Montesano R: Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sei 1995:108:73-83.
8. Pepper MS, Montesano R: Proteolytic balance and capillary morphogenesis. Cell Differ Dev 1990:32:319-328.
9. Flaumenhaft R. Rifkin DB: The extracellular regulation of growth factor action. Mol Biol Cell 1992:3: 1057-1065.
10. Vassalli J-D, Pepper MS: Membrane protease in focus. Nature 1994:370:14-15.
11. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985;44:139-266.
12. Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991:88: 1067-1072.
13. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73: 161-195.
14. Ossowski L, Clunie G, Masucci M-T, Blasi F: In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion. J Cell Biol 1991;! 15:1107-1112.
15. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sei USA. 1993:90:5021-5025.
16. Behrendt N, R0nne E, Dan0 K: The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem Hoppe Seyler 1995:376:269-279.
17. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994:269:32380-32388.
18. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degan J, Bronson R, de Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419124.
19. Bugge TH, Flick MJ, Daugherty CC, Degan JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995:9:794-807.
20. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D: Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995:92:2585-2593.
21. Bugge TH, Suh TT, Flick MJ, Daugherty CC, R0mer J, Solberg H, Ellis V. Dan0 K, Degan JL: The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 1995:270:16886-16894.
22. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene-deficient mice 1. Generation by homologous recombination and characterization. J Clin Invest 1993:92:2746-2755.
23. Carmeliet R Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D: Plasminogen activator inhibitor-1 gene-deficient mice 2. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 1993:92:2756-2760.
24. Clark ER, Clark EL: Microscopic observations on the growth of blood capillaries in the living mammal. Am J Anat 1939:64:251-301.
25. Kwaan HC, Astrup T: Fibrinolytic activity of reparative connective tissue. J Pathol Bacteriol 1964;87:409-414.
26. Larsson L-I, Skriver L, Nielsen LS, Gr0ndahl-Hansen J, Kristensen P, Dan0 K, Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 1984:98:894-903.
27. Lupu F, Heim DA, Bachmann F Hurni M, Kakkar W, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vase Biol 1995:15:1444-1455.
28. Bacharach E, Itin A, Keshet E: In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sei USA 1992:89:10686-10690.
29. Gr0ndahl-Hansen J, Kirkeby LT, Ralfkiaer E, Kristensen P, Lund LR, Dan0 K: Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol 1989:135:631-636.
30. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB: Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-2364.
31. Hildenbrand R, Dilger I, Hörlin A, Stutte HJ: Urokinase and macrophages in tumor angiogenesis. Br J Cancer 1995:72:818-823.
32. de Vries TJ, Kitson JL, Silvers WK. Mintz B: Expression of piasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. Cancer Res 1995:55: 4681-4687.
33. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicholson GL, Rao JS: Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 1994;54:3656-3661.
34. Hsu DW, Efird JT. Hedley-Whyte ET: Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 1995:147:114-123.
35. Noda-Heiny H, Daugherty A, Sobel BE: Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vase Biol 1995:15:3713.
36. Almus-Jacobs F, Varki N, Sawdey MS, Loskutoff DJ: Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am J Pathol 1995;147:688-698.
37. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicholson GL, Rao JS: Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 1994;54:5016-5020.
38. Ohtani H, Pyke C, Dan0 K, Nagura H: Expression of urokinase receptor in various stromal cell populations in human colon cancer: Immunoelectron microscopical analysis. Int J Cancer 1995:62:691-696.
39. Bianchi E, Cohen RL, Thor AT, Todd RE Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994:54:861-866.
40. Levin EG, del Zoppo GI: Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994; 144:855-861.
41. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO: Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993;13:1090-1100.
42. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ: Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993:142:59-70.
43. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dan0 K: The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991:51:40671071.
44. Delbaldo C, Cunningham M, Vassalli J-D, Sappino A-P: Plasmin-catalyzed proteolysis in colorectal neoplasia. Cancer Res 1995:55:4688-4695.
45. Yamamoto M, Sawaya R, Mohanam S, Loskutoff DJ, Brunner JM, Rao VH, Oka K, Tomonaga M, Nicholson GL. Rao JS: Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo. Cancer Res 1994:54:3329-3332.
46. Kobayashi H, Fujishiro S, Terao T: Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 1994:54:6539-6548.
47. Pepper MS, Mandriota S, Vassalli J-D, Orci L, Montesano R: Angiogenesis regulating cytokines: Activities and interactions; in Günthert U, Birchmeier W (eds): Springer, Current Topics in Microbiology and Immunology: Attempts to Understand Metastasis Formation. Berlin, Springer, 1996, vol 2., in press.
48. Montesano R, Vassalli J-D, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sei USA 1986:83:7297-7301.
49. Montesano R, Pepper MS, Belin D, Vassalli J-D, Orci L: Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J Cell Physiol 1988; 134:460-466.
50. Moscatelli D, Presta M, Rifkin DB: Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc Natl Acad Sei USA 1986;83:2091-2095.
51. Saksela O, Moscatelli D, Rifkin DB: The opposing effects of basic fibroblast growth factor and transforming growth factor-beta on the regulation of plasminogen activator in capillary endothelial cells. J Cell Biol 1987; 105:957-963.
52. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D: Transforming growth factor-beta-1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990;lll:743-755.
53. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991:181:902-906.
54. Pepper MS, Sappino A-P, Stocklin R, Montesano R, Orci L, Vassalli J-D: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993:122:673-684.
55. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R: In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 1994;210:298-305.
56. Mignatti P, Mazzieri R, Rifkin DB: Expression of urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991;! 13:1193-1202.
57. Mandriota SJ, Seghezzi G, Vassalli J-D, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995:270:9709-9716.
58. Sato Y, Rifkin DB: Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis and DNA synthesis. J Cell Biol 1988:107:1199-1205.
59. Pepper MS, Vassalli J-D, Montesano R, Orci L: Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987:105:2535-2541.
60. Pepper MS, Sappino A-P, Montesano R, Orci L, Vassalli J-D: Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol 1992:153:129-139.
61. Brown LF, Dvorak AM, Dvorak HF: Leaky vessels, fibrin deposilion. and fihrosis: A sequence of events common to solid tumors and to many other types of disease. Am Rev Respir Dis 1989:140:1104-1107.
62. Montesano R. Orci L: Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985:42:469-477.
63. Pepper MS, Ferrara N. Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992:189:824-831.
64. Fisher C. Gilbertson-Beadling S, Powers EA. Petzold G, Poorman R. Mitchell MA: Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994:162:499-510.
65. Montesano R. Pepper MS. Vassalli J-D. Orci L: Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 1987:132:509-516.
66. Pepper MS, Vassalli J-D. Orci L, Montesano R: Biphasic effect of transforming growth factor-beta-1 on in vitro angiogenesis. Exp Cell Res 1993:204:356-363.
67. Pepper MS, Montesano R, Vassalli J-D. Orci L: Chondrocytes inhibit endothelial sprout formation in vitro: Evidence for the involvement of a transforming growth factor-beta. J Cell Physiol 1991:146:170-179.
68. Bautch VL. Toda S, Hassell JA. Hanahan D: Endothelial tumors develop in transgenic mice carrying polyoma middle T oncogenc. Cell 1987:51:529-538.
69. Williams RL. Courtneidge SA. Wagner EF: Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 1988:52:121-131.
70. Williams RL. Risau W. Zerwes H-G. Drexler H. Aguzzi A. Wagner EF: Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989:57:1053-1063.
71. Pepper MS. Tacchini-Coltier F. Sabapathy TK. Montesano R. Wagner E: Endothelial cells transformed by polyomavirus middle-T oncogene: a model for hemangiomas and other vascular tumours: in Bicknell R. Lewis CE. Ferrara N (eds): Tumour Angiogenesis. Oxford. Oxford University Press. 1996. in press.
72. Montesano R. Pepper MS. Möhle-Steinlein U. Risau W. Wagner EF. Orci L: Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing middle T oncogene. Cell 1990:62:435145.
73. Dubois-Stringfellow N, Jonczyk J. Bautch VL: Perturbations in the fibrinolytic pathway aboliah cyst formation but not capillary-like organization of cultured murine endothelial cells. Blood 1994:83:3206-3217.
74. Erickson HP: Gene knockouts of c-src. transforming growth factor-βi, and tenascin suggest superfluous, nonfunctional expression of proteins. J Cell Biol 1993:120:1079-1081.
75. Mignatti P. Tsuboi R. Robbins E. Rifkin DB: In vitro angiogenesis on the human amniotic membrane: Requirements for basic fibroblast growth factor-induced proteases. J Cell Biol 1989:108:671-682.
76. Yasunaga C. Nakashima Y. Sueishi K: A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. Lab Invest 1989:61:698-704.
77. Takigawa M, Nichida Y; Suzuki F Kishi J. Yamashita K. Hayakawa T: Induction of angiogenesis in chick yolksac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP2). Biochem Biophys Res Commun 1990:171:1264-1271.
78. Sato Y. Okamura K. Morimoto A. Hamanaka R, Hamaguchi K. Shimada T. Ono M. Kohno K, Sakata T. Kuwano M: Indispensible role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp Cell Res 1993:204:223-229.
79. Schapner HW. Barnathan ES. Mazar A. Maheshwari S. Ellis S. Cortez S. Baricos WH, Kleinman HK: Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. J Cell Physiol 1995:165:107-118.
80. Schapner HW, Grant DS. Stetler-Stevenson WG. Fridman R, D'Orazi G. Murphy AN. Bird RE. Hoythya M. Fuerst TR, French DL, Quigley JP. Kleinman HK: Type IV collagenase-(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993:156:235-246.
81. Laterra J, Indurti RR. Goldstein GW: Regulation of in vitro glia-induced microvessel morphogenesis by uro kinase. J Cell Physiol 1994:158:317-324.
82. Klagsbrun M. Knoghton D. Folkman J: Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 1976:36:110-114.
83. Gimbrone MA, Cotran RS, Leapman SB. Folkman J: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974:52:413-427.
84. Andrade SP Fan T-P. Lewis GP: Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br J Exp Pat hoi 1987:68:755-766.
85. Passaniti A, Taylor RM. Pili R. Guo Y. Long PV. Haney JA. Pauly RR. Grant DS. Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin. and fibroblast growth factor. Lab Invest 1992:67:519-528.
86. Moses MA, Sudhalter J. Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 1990:248:1408-1410.
87. Albini A. Fontanini G. Masiello L. Tacchetti C. Bigini D. Luzzi P. Noonan DM, Stetler-Stevenson WG: Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KSlike lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994:8:1237-1244.
88. Galardy RE. Grobelny D, Foellmer HG. Fernandez LA: Inhibition of angiogenesis by the matrix metalloproteinase inhibitor N-[2R-2-(hydroxamidocarbonylrnethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res 1994:54:4715-1718.
89. Johnson MD, Kim H-RC, Chester L, Tsao-Wu G, Bouck N, Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinases. J Cell Physiol 1994:160:194-202.
90. Ossowski L, Russo-Payne H, Wilson EL: Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse. Cancer Res 1991;51:274-281.
91. Kobayashi H, Gotoh J, Fujie M, Shinohara H, Moniwa N, Terao T: Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model. Int J Cancer 1994:57:727-733.
92. Blei F, Wilson EL, Mignatti P, Rifkin DB: Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 1993: 155:568-578.
93. Fotsis T, Pepper M, Aldercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sei USA 1993:90:2690-2694.
94. Pepper MS, Vassalli J-D, Wilks JW, Schweigerer L, Orci L, Montesano R: Modulation of microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 1994;55:419-434.